基于循证的中医推拿治疗对比双氯芬酸二乙胺乳胶剂治疗膝骨关节炎的随机平行对照多中心临床试验
本研究为随机平行对照多中心临床试验,计划纳入300例膝骨关节炎患者,按2:1随机分为试验组(基于循证的中医推拿,每周2次,共10周,200例)和对照组(双氯芬酸二乙胺乳胶剂外用,每日3-4次,共10周,100例),主要结局为WOMAC指数变化,于基线、5周和10周评估,并比较MRI和X线评估,安全性每次治疗结束后评价。
要点
- 试验组接受基于循证的中医推拿每周2次共10周,对照组外用双氯芬酸二乙胺乳胶剂每日3-4次共10周。
- 主要结局为WOMAC指数变化,次要结局包括基于中医概念的PRO量表(CSKO)、X线和MRI评估。
- WOMAC和CSKO数据于基线、5周和10周分析,MRI和X线于基线和干预结束时分析。
核心结论
- 本研究旨在为临床医生提供治疗膝骨关节炎的补充替代疗法,并评估基于循证的中医推拿对比双氯芬酸二乙胺乳胶剂外用的有效性和安全性。
研究设计与样本
- 随机平行对照多中心临床试验,计划纳入300例膝骨关节炎患者,按2:1随机分配至试验组(200例)或对照组(100例)。
- 试验组接受基于循证的中医推拿,每周2次,共10周;对照组接受双氯芬酸二乙胺乳胶剂外用,每日3-4次,共10周。
- 两组于治疗开始后5周和10周随访,MRI和X线于基线和干预结束时进行。
- 主要结局为WOMAC指数变化,次要结局为基于中医概念的PRO量表(CSKO)、X线评估和MRI评估;显著性水平设为5%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Both massage and topically administered NSAIDs are safe and effective treatments for knee osteoarthritis (KOA); however, different massage technique sects in China caused assessment difficulties for the treatment of KOA. In order to standardize the massage techniques and procedures, we organized multi-disciplinary experts in China to acquire an evidence-based traditional Chinese medicine massage treatment of knee osteoarthritis. The purposes of this study will be to provide clinicians a complementary and alternative therapy for patients and to evaluate the efficacy and safety of evidence-based traditional Chinese medicine massage treatment of KOA compared to External Diclofenac Diethylamine Emulgel. METHODS AND DESIGN: A randomized controlled trial in which 300 participants diagnosed with KOA will be recruited and randomly allocated to either the experimental group or the control group in a ratio of 2:1. Two hundred participants will receive evidence-based traditional Chinese medicine massage 2 sessions per week for 10 weeks as the experimental group, and 100 participants will receive External Diclofenac Diethylamine Emulgel 3-4 times per day for 10 weeks as the control group. The patients in the two groups will receive follow-up at two time points at 5 weeks and 10 weeks from the beginning of treatment, respectively. The MRI scans and X-ray will be performed at baseline and at the end of the intervention. The primary outcome will be the changes in the Western Ontario and McMaster Osteoarthritis Index (WOMAC). Secondary outcomes will be measured by the PRO scale for knee osteoarthritis based on the concept of traditional Chinese medicine (Chinese scale for knee osteoarthritis (CSKO)), X-ray evaluation, and MRI scan evaluation. The data of WOMAC and CSKO will be analyzed at the baseline, 5 weeks, and 10 weeks from the beginning of treatment. The data from MRI scans and X-rays will be analyzed at baseline and at the end of the intervention. The significance level sets as 5%. The safety of interventions will be evaluated after each treatment session. DISCUSSION: This study will provide clinicians with much-needed knowledge for the treatment of KOA through a controlled trial. TRIAL REGISTRATION: Chinese Clinical Trial Registry ChiCTR1800014400 . Registered on 10 January 2018.
引用
- Wen-Yue W, Ying-Peng X, Quan-Mao D, et al. A randomized, parallel control and multicenter clinical trial of evidence-based traditional Chinese medicine massage treatment VS External Diclofenac Diethylamine Emulgel for the treatment of knee osteoarthritis. Trials. 2022. PMID: 35804406. doi:10.1186/s13063-022-06388-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。